[Post-schizophrenic depression].
Higuchi
Hidejiro
H
Fukkokai Soubu Hospital.
D000928:Antidepressive Agents / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003866:Depressive Disorder / Q000453:epidemiology / Q000209:etiology* / Q000523:psychology* / Q000628:therapy; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D012559:Schizophrenia / Q000150:complications*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D000928:Antidepressive Agents; D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D008094:Lithium; D017367:Selective Serotonin Reuptake Inhibitors